Published
Enfortumab wedotyny w dawce 30 mg w ramach realizacji B.141 - Leczenie pacjentów z rakiem urotelialnym
Notice number: 08df2e8e-1292-45da-701a-d0000155f2d3
🇵🇱 PolandUniwersytecki Szpital Kliniczny w PoznaniuGoods
KEY INFORMATION
- Submission deadline
- • Oct 27, 2026
- Location
- 🇵🇱 Poland
- Contracting authority
- Uniwersytecki Szpital Kliniczny w Poznaniu
- Accepted Languages
- Polish
- Tender type
- Goods
- Contract Value
- Published date
- Oct 20, 2026
TENDER DESCRIPTION
Enfortumab vedotin at a dose of 30 mg as part of task B.141 - Treatment of patients with urothelial cancer Enfortumab vedotin at a dose of 30 mg as part of task B.141 - Treatment of patients with urothelial cancer
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 2 FILES
- Tender detail pageLINK
- Offer Submission PlatformLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
You
Can a foreign company apply?
Riko
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.
First monitor on Day 1All features included in trialNo credit card required